naion semaglutide news More research needed on possible ocular side effects of semaglutides Novo Nordisk refutes link between

207 Liraglutide treatment was also demonstrated to inhibit beta-cell apoptosis in isolated human pancreatic beta-cells, and after 24 hours, the islet beta-cell proliferation rate tripled

The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obese), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Contrave can also be taken by: Adults looking for mild to moderate weight loss People who also have depression or binge eating disorder, Contrave may help with mood and cravings Those who prefer taking a daily pill instead of weekly injections Only approved for use in adults (18 and older) If you prefer tablets over injections or do not require significant weight loss (above 10%), Contrave may be right for you

Birth Defects Res C Embryo Today

Commentary Coloradans need protection from counterfeit weight-loss drugs and ingredients With emergence of gray market for GLP-1 medications, leaders must act Boxes of the GLP-1 drug Ozempic rest on a pharmacy counter in Los Angeles